Kuopio-based Marginum bags €2.5M to expand its fluorescence-based tumour detection tech

.kt-inside-inner-col,.kadence-column33341_8edb8a-02 > .kt-inside-inner-col:before{border-top-left-radius:0px;border-top-right-radius:0px;border-bottom-right-radius:0px;border-bottom-left-radius:0px;}.kadence-column33341_8edb8a-02 > .kt-inside-inner-col{column-gap:var(–global-kb-gap-sm, 1rem);}.kadence-column33341_8edb8a-02 > .kt-inside-inner-col{flex-direction:column;}.kadence-column33341_8edb8a-02 > .kt-inside-inner-col > .aligncenter{width:100%;}.kadence-column33341_8edb8a-02 > .kt-inside-inner-col:before{opacity:0.3;}.kadence-column33341_8edb8a-02{position:relative;}@media all and (max-width: 1024px){.kadence-column33341_8edb8a-02 > .kt-inside-inner-col{flex-direction:column;justify-content:center;}}@media all and (max-width: 767px){.kadence-column33341_8edb8a-02 > .kt-inside-inner-col{display:flex;column-gap:var(–global-kb-gap-none, 0rem );flex-direction:row;flex-wrap:wrap;justify-content:flex-start;align-items:center;}.kadence-column33341_8edb8a-02 > .kt-inside-inner-col > *, .kadence-column33341_8edb8a-02 > .kt-inside-inner-col > figure.wp-block-image, .kadence-column33341_8edb8a-02 > .kt-inside-inner-col > figure.wp-block-kadence-image{margin-top:0px;margin-bottom:0px;}.kadence-column33341_8edb8a-02 > .kt-inside-inner-col > .kb-image-is-ratio-size{flex-grow:1;}}]]]]]]]]]]>]]]]]]]]>]]]]]]>]]]]>]]>

]]]]]]]]>]]]]]]>]]]]>]]>

.kt-inside-inner-col{display:flex;}.kadence-column33341_67ccb3-83 > .kt-inside-inner-col,.kadence-column33341_67ccb3-83 > .kt-inside-inner-col:before{border-top-left-radius:0px;border-top-right-radius:0px;border-bottom-right-radius:0px;border-bottom-left-radius:0px;}.kadence-column33341_67ccb3-83 > .kt-inside-inner-col{column-gap:var(–global-kb-gap-none, 0rem );}.kadence-column33341_67ccb3-83 > .kt-inside-inner-col{flex-direction:row;flex-wrap:wrap;align-items:center;}.kadence-column33341_67ccb3-83 > .kt-inside-inner-col > *, .kadence-column33341_67ccb3-83 > .kt-inside-inner-col > figure.wp-block-image, .kadence-column33341_67ccb3-83 > .kt-inside-inner-col > figure.wp-block-kadence-image{margin-top:0px;margin-bottom:0px;}.kadence-column33341_67ccb3-83 > .kt-inside-inner-col > .kb-image-is-ratio-size{flex-grow:1;}.kadence-column33341_67ccb3-83 > .kt-inside-inner-col:before{opacity:0.3;}.kadence-column33341_67ccb3-83{position:relative;}.kadence-column33341_67ccb3-83, .kt-inside-inner-col > .kadence-column33341_67ccb3-83:not(.specificity){margin-bottom:20px;}@media all and (max-width: 1024px){.kadence-column33341_67ccb3-83 > .kt-inside-inner-col{flex-direction:row;flex-wrap:wrap;align-items:center;}}@media all and (min-width: 768px) and (max-width: 1024px){.kadence-column33341_67ccb3-83 > .kt-inside-inner-col > *, .kadence-column33341_67ccb3-83 > .kt-inside-inner-col > figure.wp-block-image, .kadence-column33341_67ccb3-83 > .kt-inside-inner-col > figure.wp-block-kadence-image{margin-top:0px;margin-bottom:0px;}.kadence-column33341_67ccb3-83 > .kt-inside-inner-col > .kb-image-is-ratio-size{flex-grow:1;}}@media all and (max-width: 767px){.kadence-column33341_67ccb3-83 > .kt-inside-inner-col{flex-direction:row;flex-wrap:wrap;justify-content:flex-start;}.kadence-column33341_67ccb3-83 > .kt-inside-inner-col > *, .kadence-column33341_67ccb3-83 > .kt-inside-inner-col > figure.wp-block-image, .kadence-column33341_67ccb3-83 > .kt-inside-inner-col > figure.wp-block-kadence-image{margin-top:0px;margin-bottom:0px;}.kadence-column33341_67ccb3-83 > .kt-inside-inner-col > .kb-image-is-ratio-size{flex-grow:1;}}]]]]]]]]]]>]]]]]]]]>]]]]]]>]]]]>]]>

August 25, 2025

Last update:

August 25, 2025

span{box-shadow:none !important;filter:brightness(1) !important}.ns-block-577254ae-4f69-44a4-9dad-6b5462f0d001 .ns-button-icon *,.ns-block-577254ae-4f69-44a4-9dad-6b5462f0d001 .ns-button-label span{color:var(–accent)}.ns-block-577254ae-4f69-44a4-9dad-6b5462f0d001 .ns-button:hover .ns-button-icon *,.ns-block-577254ae-4f69-44a4-9dad-6b5462f0d001 .ns-button:hover .ns-button-label span{color:#cfd1d2}]]]]]]]]]]>]]]]]]]]>]]]]]]>]]]]>]]>

The Kuopio-based medtech company raised €2.5M funding to bring a breakthrough therapy closer to patients suffering from brain tumours.

Get access to the full article? Become our friend

Become our friend to join our community and get access to continue reading.

Why? We’re Silicon Canals, an independent, privately owned, media company bringing you technology and startups news from all over Europe. For free. Our news coverage will remain free but for subscribers only, while our premium content will be accessible for our paying members: who we like to call our BFFs!

Topics:

]]]]]]]]>]]]]]]>]]]]>]]>

Vigneshwar has been a News Reporter at Silicon Canals since 2018. A seasoned technology journalist with almost a decade of experience, he covers the European startup ecosystem, from AI and Web3 to clean energy and health tech. Previously, he was a content producer and consumer product reviewer for leading Indian digital media, including NDTV, GizBot, and FoneArena. He graduated with a Bachelor’s degree in Electronics and Instrumentation in Chennai and a Diploma in Broadcasting Journalism in New Delhi.

Source link